Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
AOD-9604 produces no IGF-1 elevation, potentially making it more appropriate for individuals with cancer history or elevated baseline cancer risk
Last reviewed: June 9, 2026 Last updated: June 9, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Diminishing returns and plateaus: Each successive cycle typically produces less dramatic changes than the first
beware of skin-lightening products that promise instant results
2: Eder K, Felgner J, Becker K, Kluge H
US$ 26.57
US$ 20.72
US$ 21.89
US$ 28.73
US$ 24.62
